Neoadjuvant Therapy As a Platform for Drug Development: Current Controversies and Regulatory Perspectives

Oncology (Williston Park). 2015 Nov;29(11):843-4, 846.
No abstract available

MeSH terms

  • Biomarkers, Tumor
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Drug Discovery*
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Tumor Microenvironment

Substances

  • Biomarkers, Tumor